Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients

Performance assessment of 11 commercial serological tests for SARS-CoV-2 on hospitalised COVID-19 patients

Background: Commercial availability of serological tests to evaluate immunoglobulins (Ig) targeting severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has grown exponentially since the start of the coronavirus disease 2019 (COVID-19) outbreak. Thorough validation of these tests is importan...

Full description

Bibliographic Details
Main Authors: C. Serre-Miranda, C. Nobrega, S. Roque, J. Canto-Gomes, C.S. Silva, N. Vieira, P. Barreira-Silva, P. Alves-Peixoto, J. Cotter, A. Reis, M. Formigo, H. Sarmento, O. Pires, A. Carvalho, D.Y. Petrovykh, L. Diéguez, J.C. Sousa, N. Sousa, C. Capela, J.A. Palha, P.G. Cunha, M. Correia-Neves
Format: Article
Language:English
Published: Elsevier 2021-03-01
Series:International Journal of Infectious Diseases
Subjects:
COVID-19
Serological tests
Qualitative and semiquantitative tests
Sensitivity
Specificity
Clinical presentation
Online Access:http://www.sciencedirect.com/science/article/pii/S1201971221000497

Internet

http://www.sciencedirect.com/science/article/pii/S1201971221000497

Similar Items